MELISSA HALBEISEN: Open Payments
NPI 1770265571 · FANWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,598 in 30 payments from 8 companies in 2025. Trend: 2023 $174 · 2024 $200 · 2025 $1,598
Food & beverage: $934Travel & lodging: $665
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 13 | $1,320 |
| Novartis Pharmaceuticals Corporation | 6 | $94 |
| Merck Sharp & Dohme LLC | 3 | $58 |
| Amgen Inc. | 3 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Edwards Lifesciences Corporation | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
| Vital Connect, Inc | 1 | $14 |
Products named: WATCHMAN Access System, WATCHMAN FLX, LEQVIO, VERQUVO, REPATHA, CAMZYOS, ENTRESTO, SAPIEN 3 Ultra RESILIA.
Industry payments across NJ — which companies pay providers there.
